Aluminum Hydroxide
Adjuvant in
Anthrax, DTaP, DT, Td, Hib, Hib-Hepatitis B, Hepatitis A and Lyme vaccines
Synonyms:
hydrated alumina, aluminum hydroxide
Stability:
stable. Incompatible with strong bases
Toxicology: May
act as a skin, respiratory or eye irritant
Safety: S26 (In
case of contact with eyes, rinse immediately with plenty of water and seek medical
advice), S36 (Weart suitable protective clothing)
http://physchem.ox.ac.uk/MSDS/AL/aluminium_hydroxide.html
The
CDC held a meeting back in May of 2000 on Aluminum in Vaccines in Puerto Rico. Very
interesting comments made like aluminum is not perceived as bad and they felt much more
comfortable defending its presence in vaccines. They actually tagged aluminum
and found it migrated to the lymph nodes 2-5 days after vaccination. They acknowledge
that vaccination can shift the immune system to TH2 in an infant and discuss the chemical
concept of "N-Rate" where the body has a protective capacity to a point, but if
you raise the dose high enough you get breakthrough and toxicity. (Funny how they admit
this concept for aluminum but not mercury!) Oh and "The days are over when
closed door are the response to the press. Although not a juicy as Simpsonwood, these are
very interesting minutes. Yes, aluminum definitely deserves closed scrutiny.
-nurse practitioner
This
is a very illuminating transcript. There are remarks made by Vito Caserta, who
is with the NVICP, that appear to indicate that he is telling them how to
write a report so that judges will not be 'confused about causation' over the
objections of the study's author Dr. Roman Gherardi. Many of the usual suspects were
involved at this meeting.
In light of Simpsonwood the
entire transcript is a good read and on page 152 one of the participants even says,
"First of all was this conference simply thimerosal 2? You know, the same
conference with a new cast of characters, not even a new cast of characters but a new
topic, a new incarnation."
http://www.vaccinetruth.org
Aluminun
Hydroxide is a form of Aluminum. Aluminum is harmful to all life forms.
It damages all types of tissue. Aluminum is a protoplasmic poison and a deadly,
persistent neurotoxin. No living systems use aluminum as part of a biochemical
process. Ironically, the American Academy of Pediatrics admits that Aluminum
is now being implicated as interfering with a variety of cellular and metabolic processes
in the nervous system and in other tissues. As of today, it is still in vaccines. Aluminum
is a known toxin that can cause encephalitis, bone disease and anemia in susceptible
people. The kidneys eliminate Aluminum from the body and so people with renal problems are
at risk of Aluminum toxicity. All infants have reduced renal function and may not be able
to effectively excrete excessive Aluminum. Kidney function is low at birth and reaches
adult level by 1-2 years of age. The presence of Aluminum in a vaccine can cause small
nodules to develop under the skin of some babies. These nodules are usually transient in
nature and disappear spontaneously after a few weeks. In rare cases extreme
hypersensitivity to Aluminum results in persistent nodules. Early studies also suggested a
relationship between Aluminum compounds and an increased incidence of allergic diseases. Aluminum is less toxic than mercury,
arsenic, lead or cadmium, but it appears to be more persistent than most of them. The
danger is one that only manifests itself over long periods of time.
"Aluminum hydroxide
is used in vaccines to increase the body's production of antibodies , though no one knows
how it works," says Purdue researcher Stanley Hem , professor of industrial and
physical pharmacy. "The most popular theory was that it remained in the muscle for
months while the body produced antibodies in response to the antigens carried on its
surface." During the 1930s, researchers discovered that using aluminum
hydroxide to carry antigens into the body resulted in a greater production of antibodies
than could be produced by the antigen alone. Antibodies are proteins made by the immune
system to fight off foreign substances. Antigens, the proteins or molecules that stimulate
the immune system to create antibodies, are condensed and collected on the surface of
aluminum hydroxide particles. Since 1934, aluminum hydroxide has been used as an
adjuvant to boost the immune response from vaccines. Currently, it is the only adjuvant
approved by the Food and Drug Administration for use in human vaccines. The FDA limits the
dosage to 0.85 milligrams per vaccine to minimize exposure to aluminum. "There's been
some interest in other materials, but no one has proven them safe enough," Hem says. Children
can often receive up to 3.75 mg of parenteral aluminum during the first six months of
life. In a study done by Redhead K, Quinlan GJ, Das RG, Gutteridge JM, and the Division of
Bacteriology, National Institute for Biological Standards and Control, Herts., UK, they
found the injection of aluminum adsorbed vaccines into mice causes a transient rise in
brain tissue aluminum levels peaking around the second and third day after
injection. Here is the web address for the whole study.
www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1608913&dopt=Abstract
MMF is a "new
disease" due to aluminum hydroxide
For years, Aluminum has been used
as an adjuvant in vaccines for stimulating the immune system. Many
vaccinated individuals develop nodules at the injection site which last several
weeks. These nodules can inflame and turn into an aseptic abscess (puss).
Damage of the injected tissue also takes place. According to the World
Organization, lymph nodes have also been found to be effected by aluminum hydroxide.
The aseptic abscesses can also indicate a development of aluminum
hypersensitivity. Recently, some of the reported adverse
effects to aluminum exposure are, Alzheimer's, dementia, hyperactivity and learning
disorders in children.
High antibody levels production is a known
reaction to aluminum exposure. With Alzheimer's and dementia patients that have high
aluminum body content, a common characteristic is the impaired blood-brain barrier.
A clear sign that the aluminum has permeated through the barrier.
Aluminum hydroxide also contributes to
muscle pain throughout the body. Exposure to aluminum hydroxide can cause
"persistent systemic immune activation that fails to switch off". Thus
causing chronic fatigue and myalgia (muscle pain). As I research the
consequences of aluminum hydroxide, I can only conclude that it is a plausible link to
fibromyalgia.
Due to the exposure of aluminum,
Macrophagic myofasciitis (MMF) is an emerging condition. Basically, this is
the condition in which lung tissues have been traumatically torn. MMF cases have
been "found" in France, USA, England, Germany, Portugal and Spain. The
foreign chemical substance found in the lungs and white blood cells of these patients is
aluminum hydroxide traced to vaccines containing this component.
MMF patients commonly suffer from fatigue
and muscle pain studied to be an onset of aluminum hydroxide-containing vaccines such as
Hepatitis B, Hepatitis A and Tetanus. In the study of
MMF patients, of which there were 50, 98% experienced myalgia (muscle pain) which were
increasing. Thirty percent of them experienced myalgia within three months of
immunization; 61% within one year and 80% within two years. Of these 50 studied
patients, ALL of them had been inoculated 3 months to 8 years before the study by aluminum
hydroxide-containing vaccines. Thus, the results of the study
establish the fact that aluminum hydroxide-containing vaccines are a direct cause of MMF
lesions (torn lung tissue). This is plausibly related to such vaccines in the early
1990s. The World Health Organization has made the "educated guess"
that individuals with impaired abilities due to aluminum exposure are
predisposed to MMF.
Cutaneous Pseudolymphoma Tied
to Vaccinations Containing Aluminum
Hydroxide
NEW
YORK (Reuters Health) Apr 25 -
Vaccinations containing aluminum
hydroxide may induce cutaneous lymphoid hyperplasia (CLH), also called cutaneous
pseudolymphoma, according to a report in the April Journal of the American Academy of
Dermatology.
"Long lasting cutaneous lesions occurring at the site of vaccination containing
aluminum should lead to biopsy and the search for aluminum in the lymphocytic
reaction," Dr. Herve Bachelez from Hopital Saint-Louis, Paris, France told Reuters
Health.
Dr. Bachelez and colleagues investigated 9 patients presenting with late-onset, persistent
CLH at the site of hepatitis B (8 patients) or hepatitis A (1 patient) vaccination. The
vaccines were all aluminum hydroxide-adsorbed and the lesions appeared a median 3 months
after a recall injection of the vaccine.
Histologic evaluation of skin biopsies showed a pandermal dense lymphocytic infiltrate
without evidence of cytonuclear atypia, consistent with the diagnosis of CLH.
Muscle biopsies years after the appearance of the skin lesions in 2 patients revealed
focal lymphocytic microvasculitis in the muscle tissue in one case and lymphoid
hyperplasia in perimuscular fat tissue in the second case.
Electron microscopy and immunohistochemical studies identified aluminum hydroxide within
the skin infiltrates in all cases, the researchers note. Four patients had their lesions
excised surgically, and two patients were treated successfully with intralesional steroid
injection.
These findings, the researchers conclude, warrant "further prospective studies to
evaluate the incidence and the clinical course of CLH in the population receiving aluminum
hydroxide-containing vaccinations."
J Am Acad Dermatol
April 2005 • Volume 52 • Number 4
Report
Vaccination-induced cutaneous pseudolymphoma
Abstract
Background: Although mild early cutaneous transient reactions to vaccinations are common,
late-onset chronic lesions have been scarcely reported. We report herein a series of 9
patients presenting with cutaneous and subcutaneous pseudolymphoma.
Observations: Nine patients presenting with late-onset, chronic skin lesions occurring at
the site of antihepatitis B (8 cases) and antihepatitis A (one case) vaccination were
reported. Histopathologic and immunohistochemic studies, and molecular analysis of
clonality of skin biopsy specimens, were performed. Furthermore, the presence of vaccine
products was investigated in skin lesions by using histochemical, microanalytic, and
electronic microscopy techniques.
Results: Histopathologic studies showed dermal and hypodermal lymphocytic follicular
infiltrates with germinal center formation. The center of follicles was mostly composed of
B cells without atypia, whereas CD4+ T cells were predominant at the periphery. Molecular
analysis of clonality revealed a polyclonal pattern of B-cell and T-cell subsets.
Aluminium deposits were evidenced in all cases by using histochemical staining in all
cases, and by microanalysis and ultrastructural studies in one case. Associated
manifestations were vitiligo (one case) and chronic fatigue with myalgia (two cases).
Conclusion: Cutaneous lymphoid hyperplasia is a potential adverse effect of vaccinations
including aluminium hydroxide as an adjuvant. Further prospective studies are warranted to
evaluate the incidence of this complication in the immunized population.
